-
- Tutte le centrifughe
- Centrifughe da banco
- Centrifughe da pavimento
- Centrifughe refrigerate
- Microcentrifughe
- Centrifughe multiuso
- Centrifughe ad alta velocità
- Ultracentrifughe
- Concentratore
- Prodotti IVD
- High-Speed and Ultracentrifuge Consumables
- Provette per centrifughe
- Piastre per centrifughe
- Gestione degli apparecchi
- Gestione di campioni e informazioni
-
- Tutte le pipette, i dispenser e i sistemi automatizzati per la manipolazione dei liquidi
- Pipette meccaniche
- Pipette elettroniche
- Pipette multicanale
- Pipette e dispenser a spostamento positivo
- Puntali per pipette
- Dispenser per flaconi
- Controller per pipette
- Accessori per dispenser e pipette
- Pipettaggio automatico
- Consumabili per l'automazione
- Accessori per l'automazione
- Servizi di assistenza per dispenser e pipette
Read more
Read less
CAR-T Cells: Breakthroughs in Cancer and Auto-Immune Therapies
Approfondisci
CAR-T Cell Development – The Future of Fighting Cancer
CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s cells must be individually processed. Allogeneic CAR-T cells, on the other hand, currently do not have the same safety profile, necessitating further research to address these issues.
Downloads